Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flepp

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
AIDS (London, England)|December 4, 2004
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre studyClaudine Zellweger, Milos Opravil, Enos Bernasconi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
Schweizerische Medizinische Wochenschrift|April 5, 1986
[Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]M Flepp, M G Täuber, R Lüthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control studyHelen Kovari, Bruno Ledergerber, Ulrich Peter, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
HIV Medicine|December 12, 2001
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patientsM Battegay, P L Vernazza, E Bernasconi, et al.
AIDS Research and Human Retroviruses|December 16, 2004
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control studyBarbara Hasse, Bruno Ledergerber, Matthias Egger, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort StudyKatja Wolf, James Young, Martin Rickenbach, et al.
AIDS (London, England)|August 1, 1997
Effect of antiviral treatment on the shedding of HIV-1 in semenP L Vernazza, B L Gilliam, M Flepp, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
AIDS (London, England)|December 4, 2004
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre studyClaudine Zellweger, Milos Opravil, Enos Bernasconi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
Schweizerische Medizinische Wochenschrift|April 5, 1986
[Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]M Flepp, M G Täuber, R Lüthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control studyHelen Kovari, Bruno Ledergerber, Ulrich Peter, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
HIV Medicine|December 12, 2001
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patientsM Battegay, P L Vernazza, E Bernasconi, et al.
AIDS Research and Human Retroviruses|December 16, 2004
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control studyBarbara Hasse, Bruno Ledergerber, Matthias Egger, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort StudyKatja Wolf, James Young, Martin Rickenbach, et al.
AIDS (London, England)|August 1, 1997
Effect of antiviral treatment on the shedding of HIV-1 in semenP L Vernazza, B L Gilliam, M Flepp, et al.
Pageof 12